Liaoning He Eye Hospital Group Co. LTD. (SHE:301103) — Market Cap & Net Worth
Market Cap & Net Worth: Liaoning He Eye Hospital Group Co. LTD. (301103)
Liaoning He Eye Hospital Group Co. LTD. (SHE:301103) has a market capitalization of $364.21 Million (CN¥2.49 Billion) as of August 4, 2026. Listed on the SHE stock exchange, this China-based company holds position #13745 globally and #4052 in its home market, demonstrating a 4.03% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Liaoning He Eye Hospital Group Co. LTD.'s stock price CN¥15.75 by its total outstanding shares 158026471 (158.03 Million). See 301103 capex to operating cash flow ratio to understand how much of operating cash flow is reinvested back into capital assets.
Liaoning He Eye Hospital Group Co. LTD. Market Cap History: 2022 to 2026
Liaoning He Eye Hospital Group Co. LTD.'s market capitalization history from 2022 to 2026. Data shows change from $692.28 Million to $376.23 Million (-17.00% CAGR).
Liaoning He Eye Hospital Group Co. LTD. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Liaoning He Eye Hospital Group Co. LTD.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.42x
Liaoning He Eye Hospital Group Co. LTD.'s market cap is 0.42 times its annual revenue
Latest Price to Earnings (P/E) Ratio
16.60x
Liaoning He Eye Hospital Group Co. LTD.'s market cap is 16.60 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2022 | $692.28 Million | $955.31 Million | $32.59 Million | 0.72x | 21.24x |
| 2023 | $673.91 Million | $1.19 Billion | $63.55 Million | 0.57x | 10.60x |
| 2024 | $465.26 Million | $1.10 Billion | -$27.40 Million | 0.42x | N/A |
| 2025 | $453.70 Million | $1.09 Billion | $27.34 Million | 0.42x | 16.60x |
Competitor Companies of 301103 by Market Capitalization
Companies near Liaoning He Eye Hospital Group Co. LTD. in the global market cap rankings as of August 4, 2026.
Key companies related to Liaoning He Eye Hospital Group Co. LTD. by market ranking:
- HCA Healthcare, Inc. (NYSE:HCA): Ranked #327 globally with a market cap of $80.16 Billion USD.
- Fresenius SE & Co. KGaA (XETRA:FRE): Ranked #905 globally with a market cap of $29.19 Billion USD ( €24.97 Billion EUR).
- FRESENIUS SE+CO. ADR 1/4 (F:FREA): Ranked #994 globally with a market cap of $26.87 Billion USD ( €22.98 Billion EUR).
- IHH Healthcare Bhd (KLSE:5225): Ranked #1355 globally with a market cap of $18.52 Billion USD ( RM73.78 Billion MYR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #327 | HCA Healthcare, Inc. | NYSE:HCA | $80.16 Billion | $402.59 |
| #905 | Fresenius SE & Co. KGaA | XETRA:FRE | $29.19 Billion | €44.52 |
| #994 | FRESENIUS SE+CO. ADR 1/4 | F:FREA | $26.87 Billion | €10.20 |
| #1355 | IHH Healthcare Bhd | KLSE:5225 | $18.52 Billion | RM8.35 |
Liaoning He Eye Hospital Group Co. LTD. Historical Marketcap From 2022 to 2026
Between 2022 and today, Liaoning He Eye Hospital Group Co. LTD.'s market cap moved from $692.28 Million to $ 376.23 Million, with a yearly change of -17.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥376.23 Million | -17.07% |
| 2025 | CN¥453.70 Million | -2.49% |
| 2024 | CN¥465.26 Million | -30.96% |
| 2023 | CN¥673.91 Million | -2.65% |
| 2022 | CN¥692.28 Million | -- |
End of Day Market Cap According to Different Sources
On Aug 3rd, 2026 the market cap of Liaoning He Eye Hospital Group Co. LTD. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $364.21 Million USD |
| MoneyControl | $364.21 Million USD |
| MarketWatch | $364.21 Million USD |
| marketcap.company | $364.21 Million USD |
| Reuters | $364.21 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Liaoning He Eye Hospital Group Co. LTD.
Liaoning He Eye Hospital Group Co., LTD. provides ophthalmic specialist diagnosis, treatment, and optometry services to patients with eye diseases. It offers cataract diagnosis and treatment, refractive error surgical correction, vitreoretinal diagnosis and treatment, other surgical diagnosis and treatment services, etc. The company also provides refractive cataracts, LASIK surgery, myopia preven… Read more